Thrombophiliediagnostik

Literatur

• 1 Azem F, Many A, Ben A I, Yovel I, Amit A, Lessing J B, Kupferminc M J. Increased rates of thrombophilia in women with repeated IVF failures.  Hum Reprod. 2004;  19 368-370
• 2 Bergqvist D, Agnelli G, Cohen A T, Eldor A, Nilsson P E, Moigne-Amrani A, Dietrich-Neto F. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.  N Engl J Med. 2002;  346 975-980
• 3 Brill-Edwards P, Ginsberg J S, Gent M, Hirsh J, Burrows R, Kearon C, Geerts W, Kovacs M, Weitz J I, Robinson K S, Whittom R, Couture G. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.  N Engl J Med. 2000;  343 1439-1444
• 4 Coulam C B, Jeyendran R S, Fishel L A, Roussev R G. Multiple thrombophilic gene mutations are risk factors for implantation failure.  Reprod Biomed Online. 2006;  12 322-327
• 5 Cushman M, Kuller L H, Prentice R, Rodabough R J, Psaty B M, Stafford R S, Sidney S, Rosendaal F R. Estrogen plus progestin and risk of venous thrombosis.  JAMA. 2004;  292 1573-1580
• 6 Dalen J E. Economy class syndrome: too much flying or too much sitting?.  Arch Intern Med. 2003;  163 2674-2676
• 7 De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications.  Haematologica. 2002;  87 1095-1108
• 8 Dizon-Townson D, Hutchison C, Silver R, Branch D W, Ward K. The factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid syndrome.  Thromb Haemost. 1995;  74 1029-1031
• 9 Dizon-Townson D, Miller C, Sibai B, Spong C Y, Thom E, Wendel Jr G, Wenstrom K, Samuels P, Cotroneo M A, Moawad A, Sorokin Y, Meis P, Miodovnik M, O'Sullivan M J, Conway D, Wapner R J, Gabbe S G. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.  Obstet Gynecol. 2005;  106 517-524
• 10 Drescher S, Mörike K, Gleiter C H. Tiefe Beinvenenthrombose in der Schwangerschaft - Niedermolekulare Heparine zur Rezidivprophylaxe.  Gynäkologe. 2000;  33 547-550
• 11 Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.  Cochrane Database Syst Rev. 2005;  CD002859
• 12 Frosst P, Blom H J, Milos R, Goyette P, Sheppard C A, Matthews R G, Boers G J, den Heijer M, Kluijtmans L A, van den Heuvel L P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.  Nat Genet. 1995;  10 111-113
• 13 Ginsberg J S, Hirsh J. Use of antithrombotic agents during pregnancy.  Chest. 1992;  102 385S-390S
• 14 Grandone E, Colaizzo D, Lo B A, Checola M G, Cittadini E, Margaglione M. Inherited thrombophilia and in vitro fertilization implantation failure.  Fertil Steril. 2001;  76 201-202
• 15 Greer I A, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.  Blood. 2005;  106 401-407
• 16 Greer I A. Prevention of venous thromboembolism in pregnancy.  Best Pract Res Clin Haematol. 2003;  16 261-278
• 17 Gris J C, Mercier E, Quere I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland M L, Dauzat M, Mares P. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.  Blood. 2004;  103 3695-3699
• 18 Haggarty P, McCallum H, McBain H, Andrews K, Duthie S, McNeill G, Templeton A, Haites N, Campbell D, Bhattacharya S. Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study.  Lancet. 2006;  367 1513-1519
• 19 Hannemann-Pohl K, Stöckemann M, Kunstmann P, Knothe G, Michiels J J, Kampf S-C. D‐Dimer-Konzentration: Wann ist sie pathologisch?.  Frauenarzt. 2005;  46 198-201
• 20 Homans J. Thrombosis of the deep leg veins due to prolonged sitting.  N Engl J Med. 1954;  250 148-149
• 21 Jacques P F, Bostom A G, Selhub J, Rich S, Ellison R C, Eckfeldt J H, Gravel R A, Rozen R. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study.  Atherosclerosis. 2003;  166 49-55
• 22 Kelman C W, Kortt M A, Becker N G, Li Z, Mathews J D, Guest C S, Holman C D. Deep vein thrombosis and air travel: record linkage study.  BMJ. 2003;  327 1072
• 23 Kyrle P A, Eichinger S. Deep vein thrombosis.  Lancet. 2005;  365 1163-1174
• 24 Legnani C, Cini M, Cosmi B, Poggi M, Boggian O, Palareti G. Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels.  Haematologica. 2004;  89 1347-1351
• 25 Miyakis S, Lockshin M D, Atsumi T, Branch D W, Brey R L, Cervera R, Derksen R H, De Groot P G, Koike T, Meroni P L, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos P G, Krilis S A. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).  J Thromb Haemost. 2006;  4 295-306
• 26 Nawroth F, Strehler E, Sterzik K, Ludwig M. Habituelle Aborte - Diagnostik und Therapie.  Frauenarzt. 2006;  47 300-305
• 27 Pabinger I, Schneider B. Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S‐deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors.  Thromb Haemost. 1994;  71 548-552
• 28 Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hämostaseforschung (GTH) Study Group on Natural Inhibitors.  Arterioscler Thromb Vasc Biol. 1996;  16 742-748
• 29 Rey E, Kahn S R, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis.  Lancet. 2003;  361 901-908
• 30 Roque H, Stephenson C, Lee M J, Funai E F, Popiolek D, Kim E, Hart D. Pregnancy-related thrombosis in a woman with congenital fibrinogenemia: a report of two successful pregnancies.  Am J Hematol. 2004;  76 267-270
• 31 Schreijer A J, Cannegieter S C, Meijers J C, Middeldorp S, Buller H R, Rosendaal F R. Activation of coagulation system during air travel: a crossover study.  Lancet. 2006;  367 832-838
• 32 Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis.  N Engl J Med. 2001;  344 1222-1231
• 33 Stanger O, Hermann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M. Konsensuspapier der D.A.CH.-Liga Homocystein über den rationellen klinischen Umgang mit Homocystein, Folsäure und B‐Vitaminen bei kardiovaskulären und thrombotischen Erkrankungen - Richtlinien und Empfehlungen.  J Kardiol. 2003;  10 190-199
• 34 Thomas L. Labor und Diagnose. 6th ed. Frankfurt; Th-Books 2005
• 35 van Dunne F M, de Craen A J, Heijmans B T, Helmerhorst F M, Westendorp R G. Gender-specific association of the factor V Leiden mutation with fertility and fecundity in a historic cohort. The Leiden 85-Plus Study.  Hum Reprod. 2006;  21 967-971
• 36 von Wolff M, Strowitzki T. Habituelle Aborte - ein multifaktorielles Krankheitsbild.  Gynäkol Endokrinol. 2005;  3 7-17
• 37 Wegmann D. Paraneoplastic thrombosis - study on mortality statistics.  Vasa. 1981;  10 111-118
• 38 Wiegratz I, Lee J H, Kutschera E, Winkler U H, Kuhl H. Effect of four oral contraceptives on hemostatic parameters.  Contraception. 2004;  70 97-106
• 39 Willeke A, Gerdsen F, Bauersachs R, Lindhoff-Last E. Rationelle Thrombophiliediagnostik.  Dtsch Ärztebl. 2002;  99 A2111-A2118